Padeliporfin VTP Using Robotic Assisted Bronchoscopy in Peripheral Lung Cancer

Summary

Phase 1/1b, safety, feasibility, and light dose titration study followed by further study of therapeutic ablation effects. Patients with high risk of peripheral primary lung cancer, stage 1A1/1A2, for whom surgical treatment is planned, will be recruited. Surgery will be performed at 5-21 days following the VTP procedure. Study intervention: robotic assisted bronchoscopic Padeliporfin VTP lung ablation: vascular targeted photodynamic therapy using Padeliporfin photosensitizer.

Timeline

Start

2025-05-28

Primary completion

2027-05-30

Completion

2028-12-30

Drugs

Indications